CAROL MONROE: Open Payments
NPI 1700835345 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,721 in 124 payments from 29 companies in 2025. Trend: 2023 $2,024 · 2024 $2,056 · 2025 $2,721
Food & beverage: $2,721
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $386 |
| AstraZeneca Pharmaceuticals LP | 15 | $354 |
| Lilly USA, LLC | 15 | $270 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $241 |
| Novo Nordisk Inc | 7 | $208 |
| Otsuka America Pharmaceutical, Inc. | 7 | $200 |
| Janssen Biotech, Inc. | 7 | $173 |
| Janssen Pharmaceuticals, Inc | 2 | $130 |
| Amgen Inc. | 5 | $83 |
| Ardelyx, Inc. | 3 | $76 |
Products named: BREZTRI, CAPLYTA, REXULTI, TREMFYA, Ozempic, SKYRIZI, SPRAVATO, OMVOH.
Industry payments across MO — which companies pay providers there.
